Meningioma Overview

Save information for later
Sign Up

Learn About Meningioma

View Main Condition: Brain Tumor

What is the definition of Meningioma?
Meningiomas are tumors that originate in the meninges, the membranes that surround the brain and spinal cord. Most Meningiomas are not cancerous (benign), though a minority of Meningiomas can be classified as atypical or cancerous (malignant). Though rare, malignant Meningiomas can be highly aggressive. However, even benign Meningiomas can cause problems if their growth affects neighboring areas of the brain. Though most Meningiomas grow slowly, there is no way to predict the rate of growth for a particular Meningioma or to know how long a specific Meningioma was growing before it was diagnosed. Signs and symptoms can vary but may include seizures, headaches, weakness in the arms and legs, and vision loss. Sometimes memory loss, carelessness, and unsteadiness are the only symptoms.
What are the alternative names for Meningioma?
  • Meningioma
Who are the top Meningioma Local Doctors?
Aaron Cohen-Gadol
Dr. Aaron Cohen-Gadol
Neurosurgery
Dr. Aaron Cohen-Gadol
Neurosurgery

Keck School Of Medicine Of USC, Dept Of Neurological Surgery

1540 Alcazar St, 
Los Angeles, CA 
 2.3 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Aaron Cohen-Gadol is a Neurosurgery provider in Los Angeles, California. Dr. Cohen-Gadol and is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Meningioma, Cerebral Ventricle Cancer, Brain Tumor, Rhizotomy, and Awake Craniotomy. Dr. Cohen-Gadol is currently accepting new patients.

Dr. Gabriel Zada
Neurosurgery
Dr. Gabriel Zada
Neurosurgery

USC Care Medical Group Inc

1520 San Pablo St, Fl 4, 
Los Angeles, CA 
 2.3 mi
Offers Telehealth
Languages Spoken English

Gabriel Zada is a Neurosurgery provider in Los Angeles, California. Dr. Zada and is rated as an Elite provider by MediFind in the treatment of Meningioma. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Gamma Knife Radiosurgery.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Daniel H. Kim
Radiation Oncology
Dr. Daniel H. Kim
Radiation Oncology

USC Care Medical Group Inc

1520 San Pablo St, 
Los Angeles, CA 
 2.3 mi
Languages Spoken English

Daniel Kim is a Radiation Oncologist in Los Angeles, California. Dr. Kim has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Meningioma. His top areas of expertise are Metastatic Brain Tumor, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer.

View All Doctors
What are the latest Meningioma Clinical Trials?
Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)
Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2

Summary: This phase II trial tests the effect of decreasing (tapering) doses of dexamethasone on steroid side effects in patients after surgery to remove (craniotomy) a brain tumor. Steroids are the gold standard post-surgery treatment to reduce swelling (edema) at the surgical site to reduce neurological symptoms. Although, corticosteroids reduce edema, they have side effects including high blood sugar, h...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Device

Summary: The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 11, 2022
Published By: Genetic and Rare Diseases Informnation Center